{"id":6675,"date":"2013-12-02T11:22:42","date_gmt":"2013-12-02T11:22:42","guid":{"rendered":"https:\/\/www.bpa-solutions.net\/?p=6675"},"modified":"2023-07-10T08:27:33","modified_gmt":"2023-07-10T08:27:33","slug":"bpa-obtient-des-fonds-de-debiopharm","status":"publish","type":"post","link":"https:\/\/www.bpa-solutions.net\/fr\/bpa-get-funds-from-debiopharm\/","title":{"rendered":"BPA Solutions obtient des fonds d&#039;investissement de Debiopharm Investment"},"content":{"rendered":"<p><b><a href=\"https:\/\/www.bpa-solutions.net\/wp-content\/uploads\/2013\/12\/Debiopharm-Investment.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-6685 alignright\" src=\"https:\/\/www.bpa-solutions.net\/wp-content\/uploads\/2013\/12\/Debiopharm-Investment-300x54-1.jpg\" alt=\"Investissement Debiopharm\" width=\"300\" height=\"54\" \/><\/a>Yverdon, Suisse, 1er d\u00e9cembre 2013 <\/b>- BPA Solutions SA (BPA), dont le si\u00e8ge se trouve sur la Swiss Technopole Yverdon, en Suisse, a annonc\u00e9 aujourd'hui avoir lev\u00e9 des fonds de d\u00e9veloppement aupr\u00e8s de Debiopharm Investment.<\/p>\n<p>BPA est un fournisseur mondial de solutions logicielles innovantes bas\u00e9es sur les technologies Microsoft (MS) SharePoint, avec plus de 800 clients et plus de 50 partenaires dans le monde entier. Rentable depuis sa cr\u00e9ation, BPA fournit des solutions d'entreprise, des solutions mobiles et des services cloud qui permettent aux organisations d'\u00e9tablir des relations plus \u00e9troites avec leurs parties prenantes, qu'elles soient internes ou externes. Les solutions pr\u00eates \u00e0 l'emploi de BPA, y compris BPA CRM, Quality, Risk, Recruiting et Self-Service sont les solutions d'entreprise de la prochaine g\u00e9n\u00e9ration. Toutes les solutions sont con\u00e7ues et orient\u00e9es vers les utilisateurs finaux et fonctionnent de la m\u00eame mani\u00e8re qu'eux et non l'inverse. Les organisations ont un contr\u00f4le total sur leurs solutions et peuvent les d\u00e9ployer comme elles le souhaitent : sur site, dans des nuages priv\u00e9s ou Microsoft ou dans un environnement hybride.<\/p>\n<p>\"Nous sommes honor\u00e9s d'accueillir Debiopharm Investment dans notre \u00e9quipe. Leur vision \u00e0 long terme et leur approche centr\u00e9e sur l'humain correspondent parfaitement \u00e0 notre vision et \u00e0 notre philosophie\", a d\u00e9clar\u00e9 le Dr Boris Lutz, fondateur et PDG de BPA.  Mme Val\u00e9rie Calvayrac, CEO de Debiopharm Investment, pense que \"BPA Solution a trouv\u00e9 son march\u00e9 en Suisse et nous sommes heureux de soutenir la soci\u00e9t\u00e9 dans ses nouveaux d\u00e9fis et son d\u00e9veloppement international\".<\/p>\n<p>\"Nos produits logiciels sont d\u00e9sormais robustes et m\u00fbrs. Nous avons une proposition de vente unique. Il est temps pour BPA de passer d'une soci\u00e9t\u00e9 orient\u00e9e vers la R&amp;D \u00e0 une soci\u00e9t\u00e9 orient\u00e9e vers le marketing et les ventes \u00e0 l'\u00e9chelle mondiale. Le nouveau financement permettra \u00e0 BPA d'acc\u00e9l\u00e9rer sa croissance rapide, de poursuivre son expansion internationale avec un solide \u00e9cosyst\u00e8me de partenaires et de continuer \u00e0 d\u00e9velopper des solutions logicielles innovantes\", a d\u00e9clar\u00e9 M. Lutz. Mme Calvayrac ajoute : \"Cet esprit d'innovation permanente est l'un des aspects qui nous a le plus plu, car il est tout \u00e0 fait conforme \u00e0 notre propre philosophie d'entreprise\".<\/p>\n<p>Au cours des trois derni\u00e8res ann\u00e9es, BPA a \u00e9t\u00e9 s\u00e9lectionn\u00e9e, en tant qu'unique entreprise non nord-am\u00e9ricaine, par Microsoft Corp \u00e0 Redmond, aux \u00c9tats-Unis, pour participer \u00e0 diff\u00e9rents programmes exclusifs tels que le SharePoint Partner Advisory Board et le Technology Adoption Program pour la nouvelle version MS Office 365. L'\u00e9quipe de d\u00e9veloppement de BPA a eu la chance de travailler main dans la main avec les experts de Microsoft pour d\u00e9velopper une version office 365 de BPA CRM, en tant que premi\u00e8re application m\u00e9tier disponible pour office 365. D'autres solutions seront ajout\u00e9es en 2014.<\/p>\n<p>\"Il y a sept ans, nous avons choisi Microsoft SharePoint comme plate-forme technologique pour nos solutions. C'\u00e9tait le bon choix. Microsoft SharePoint est devenu le produit serveur de Microsoft le plus performant avec des centaines de millions d'utilisateurs dans le monde entier et il continuera \u00e0 se d\u00e9velopper avec Office 365\", d\u00e9clare Boris Lutz. BPA s'inscrit d\u00e9j\u00e0 dans la r\u00e9cente r\u00e9orientation de Microsoft vers les appareils et les services, en particulier les services en nuage (Windows Azure et Office 365) et la mobilit\u00e9 (tablettes et t\u00e9l\u00e9phones). La d\u00e9cision de Microsoft d'offrir MS Office, son joyau, aux utilisateurs d'iPhone, d'Android, de Nokia et de Blackberry via ses services Web Office 365 est encourageante. La mobilit\u00e9 est strat\u00e9gique pour la croissance de BPA, comme les services en nuage et la connectivit\u00e9 aux m\u00e9dias sociaux. Une solution mobile autonome de BPA pour iPhone vient d'\u00eatre lanc\u00e9e. Des solutions mobiles pour iPad, Android et Windows suivront bient\u00f4t. Des connecteurs de m\u00e9dias sociaux tels que LinkedIn et Xing sont sur le point d'\u00eatre lanc\u00e9s. BPA se consacre \u00e0 l'am\u00e9lioration de l'exp\u00e9rience utilisateur et \u00e0 la facilitation des relations commerciales gr\u00e2ce \u00e0 ses solutions.<\/p>\n<p>Dans les mois \u00e0 venir, BPA consolidera sa pr\u00e9sence en Am\u00e9rique du Nord, en Europe et en Asie. BPA investira dans le recrutement des meilleurs partenaires de distribution, d'h\u00e9bergement et de technologie. \"Il y a beaucoup d'opportunit\u00e9s int\u00e9ressantes pour les partenaires aujourd'hui et pour les ann\u00e9es \u00e0 venir\" dit M. Lutz. Mme Calvayrac a d\u00e9clar\u00e9 : \"Comme d'habitude, nous voulons \u00eatre un partenaire et un membre actif du conseil d'administration, pour les aider \u00e0 relever ce d\u00e9fi avec succ\u00e8s.\" Sur ce point, Boris Lutz conclut avec humour : \"La conclusion de Val\u00e9rie Calvayrac correspond \u00e0 la devise de notre BPA - de meilleures affaires gr\u00e2ce \u00e0 des relations plus \u00e9troites - et nous le prouverons avec Debiopharm\".<\/p>\n<p><b>\u00c0 propos de BPA Solutions<\/b><\/p>\n<p>BPA est un fournisseur mondial de solutions logicielles innovantes bas\u00e9es sur les technologies Microsoft SharePoint, avec plus de 800 clients et plus de 50 partenaires dans le monde entier. Rentable depuis sa cr\u00e9ation, BPA fournit des solutions m\u00e9tier, des solutions mobiles et des services cloud qui permettent aux organisations d'\u00e9tablir des relations plus \u00e9troites avec leurs parties prenantes, qu'elles soient internes ou externes. Bas\u00e9e \u00e0 Yverdon, en Suisse, BPA poss\u00e8de des bureaux \u00e0 Leesburg, aux Etats-Unis et \u00e0 Kerala, en Inde. Pour plus d'informations, veuillez consulter le site www.bpa-solutions.net<\/p>\n<p><b>\u00c0 propos de Debiopharm Investment<\/b><\/p>\n<p>La mission de Debiopharm Investment est de diversifier les investissements r\u00e9alis\u00e9s par Debiopharm Group, un groupe biopharmaceutique mondial bas\u00e9 en Suisse qui se concentre sur le d\u00e9veloppement de m\u00e9dicaments sur ordonnance ciblant des besoins m\u00e9dicaux non satisfaits. Cette diversification s'op\u00e8re notamment par la prise de participation minoritaire de la branche Private Equity dans des start-ups innovantes dans les domaines des technologies de l'information, des technologies propres et des \"services aux particuliers\".<\/p>\n<p><b>Debiopharm Investment SA Contact<\/b><br \/>\nAlexandra Le Coz Sanchez<br \/>\nDirecteur associ\u00e9, gestionnaire de capital-investissement<br \/>\n<a href=\"mailto:private-equity@debiopharm.com\">private-equity@debiopharm.com<\/a><br \/>\nT\u00e9l : +41 (0)21 321 01 11<\/p>\n<p><b>BPA Solutions SA Contact<\/b><br \/>\nDr Boris Lutz<br \/>\nFondateur et PDG<br \/>\n<a href=\"mailto:info@bpa-solutions.net\">info@bpa-solutions.net<\/a><br \/>\nT\u00e9l : +41 (0)32 710 17 07<\/p>","protected":false},"excerpt":{"rendered":"<p>Yverdon, Switzerland, December 1, 2013 \u2013 BPA Solutions SA (BPA), headquartered at Swiss Technopole Yverdon, Switzerland, today announced it has raised development funds from Debiopharm Investment. BPA is a global leading provider of innovative business software solutions based on Microsoft (MS) SharePoint technologies with 800+ customers and 50+ partners worldwide. Profitable since inception, BPA delivers [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","content-type":"","inline_featured_image":false,"footnotes":""},"categories":[64,58,61],"tags":[84,85,86],"class_list":["post-6675","post","type-post","status-publish","format-standard","hentry","category-bpa-solutions","category-news-about","category-press-release","tag-debiopharm","tag-funds","tag-investor"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BPA Solutions get Investment Funds from Debiopharm Investment - BPA Solutions<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bpa-solutions.net\/fr\/bpa-obtient-des-fonds-de-debiopharm\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BPA Solutions get Investment Funds from Debiopharm Investment - BPA Solutions\" \/>\n<meta property=\"og:description\" content=\"Yverdon, Switzerland, December 1, 2013 \u2013 BPA Solutions SA (BPA), headquartered at Swiss Technopole Yverdon, Switzerland, today announced it has raised development funds from Debiopharm Investment. BPA is a global leading provider of innovative business software solutions based on Microsoft (MS) SharePoint technologies with 800+ customers and 50+ partners worldwide. Profitable since inception, BPA delivers [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bpa-solutions.net\/fr\/bpa-obtient-des-fonds-de-debiopharm\/\" \/>\n<meta property=\"og:site_name\" content=\"BPA Solutions\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/BPASolutions?fref=ts\" \/>\n<meta property=\"article:published_time\" content=\"2013-12-02T11:22:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-10T08:27:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bpa-solutions.net\/wp-content\/uploads\/2013\/12\/Debiopharm-Investment-300x54-1.jpg\" \/>\n<meta name=\"author\" content=\"Boris Lutz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BPA_SOLUTIONS\" \/>\n<meta name=\"twitter:site\" content=\"@BPA_SOLUTIONS\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Boris Lutz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/bpa-get-funds-from-debiopharm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/bpa-get-funds-from-debiopharm\\\/\"},\"author\":{\"name\":\"Boris Lutz\",\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/#\\\/schema\\\/person\\\/1752d1ec96e94ebb1316bd53a2bd57ae\"},\"headline\":\"BPA Solutions get Investment Funds from Debiopharm Investment\",\"datePublished\":\"2013-12-02T11:22:42+00:00\",\"dateModified\":\"2023-07-10T08:27:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/bpa-get-funds-from-debiopharm\\\/\"},\"wordCount\":807,\"publisher\":{\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/bpa-get-funds-from-debiopharm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bpa-solutions.net\\\/wp-content\\\/uploads\\\/2013\\\/12\\\/Debiopharm-Investment-300x54-1.jpg\",\"keywords\":[\"Debiopharm\",\"funds\",\"investor\"],\"articleSection\":[\"BPA Solutions\",\"News\",\"Press Release\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/bpa-get-funds-from-debiopharm\\\/\",\"url\":\"https:\\\/\\\/www.bpa-solutions.net\\\/bpa-get-funds-from-debiopharm\\\/\",\"name\":\"BPA Solutions get Investment Funds from Debiopharm Investment - BPA Solutions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/bpa-get-funds-from-debiopharm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/bpa-get-funds-from-debiopharm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bpa-solutions.net\\\/wp-content\\\/uploads\\\/2013\\\/12\\\/Debiopharm-Investment-300x54-1.jpg\",\"datePublished\":\"2013-12-02T11:22:42+00:00\",\"dateModified\":\"2023-07-10T08:27:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/bpa-get-funds-from-debiopharm\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bpa-solutions.net\\\/bpa-get-funds-from-debiopharm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/bpa-get-funds-from-debiopharm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bpa-solutions.net\\\/wp-content\\\/uploads\\\/2013\\\/12\\\/Debiopharm-Investment-300x54-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.bpa-solutions.net\\\/wp-content\\\/uploads\\\/2013\\\/12\\\/Debiopharm-Investment-300x54-1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/bpa-get-funds-from-debiopharm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.bpa-solutions.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BPA Solutions get Investment Funds from Debiopharm Investment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/#website\",\"url\":\"https:\\\/\\\/www.bpa-solutions.net\\\/\",\"name\":\"BPA Solutions\",\"description\":\"Intuitive, secure, intelligent eQMS on SharePoint Microsoft 365 AI\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bpa-solutions.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/#organization\",\"name\":\"BPA Solutions\",\"url\":\"https:\\\/\\\/www.bpa-solutions.net\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.bpa-solutions.net\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/BPA-Solutions.svg\",\"contentUrl\":\"https:\\\/\\\/www.bpa-solutions.net\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/BPA-Solutions.svg\",\"width\":301,\"height\":68,\"caption\":\"BPA Solutions\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/BPASolutions?fref=ts\",\"https:\\\/\\\/x.com\\\/BPA_SOLUTIONS\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bpa-solutions.net\\\/#\\\/schema\\\/person\\\/1752d1ec96e94ebb1316bd53a2bd57ae\",\"name\":\"Boris Lutz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7a92d8e8012b5fadbae634d6ed1315aa081e51ebf627599d0e53bd99e362775c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7a92d8e8012b5fadbae634d6ed1315aa081e51ebf627599d0e53bd99e362775c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7a92d8e8012b5fadbae634d6ed1315aa081e51ebf627599d0e53bd99e362775c?s=96&d=mm&r=g\",\"caption\":\"Boris Lutz\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BPA Solutions get Investment Funds from Debiopharm Investment - BPA Solutions","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bpa-solutions.net\/fr\/bpa-obtient-des-fonds-de-debiopharm\/","og_locale":"fr_FR","og_type":"article","og_title":"BPA Solutions get Investment Funds from Debiopharm Investment - BPA Solutions","og_description":"Yverdon, Switzerland, December 1, 2013 \u2013 BPA Solutions SA (BPA), headquartered at Swiss Technopole Yverdon, Switzerland, today announced it has raised development funds from Debiopharm Investment. BPA is a global leading provider of innovative business software solutions based on Microsoft (MS) SharePoint technologies with 800+ customers and 50+ partners worldwide. Profitable since inception, BPA delivers [&hellip;]","og_url":"https:\/\/www.bpa-solutions.net\/fr\/bpa-obtient-des-fonds-de-debiopharm\/","og_site_name":"BPA Solutions","article_publisher":"https:\/\/www.facebook.com\/BPASolutions?fref=ts","article_published_time":"2013-12-02T11:22:42+00:00","article_modified_time":"2023-07-10T08:27:33+00:00","og_image":[{"url":"https:\/\/www.bpa-solutions.net\/wp-content\/uploads\/2013\/12\/Debiopharm-Investment-300x54-1.jpg","type":"","width":"","height":""}],"author":"Boris Lutz","twitter_card":"summary_large_image","twitter_creator":"@BPA_SOLUTIONS","twitter_site":"@BPA_SOLUTIONS","twitter_misc":{"\u00c9crit par":"Boris Lutz","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bpa-solutions.net\/bpa-get-funds-from-debiopharm\/#article","isPartOf":{"@id":"https:\/\/www.bpa-solutions.net\/bpa-get-funds-from-debiopharm\/"},"author":{"name":"Boris Lutz","@id":"https:\/\/www.bpa-solutions.net\/#\/schema\/person\/1752d1ec96e94ebb1316bd53a2bd57ae"},"headline":"BPA Solutions get Investment Funds from Debiopharm Investment","datePublished":"2013-12-02T11:22:42+00:00","dateModified":"2023-07-10T08:27:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bpa-solutions.net\/bpa-get-funds-from-debiopharm\/"},"wordCount":807,"publisher":{"@id":"https:\/\/www.bpa-solutions.net\/#organization"},"image":{"@id":"https:\/\/www.bpa-solutions.net\/bpa-get-funds-from-debiopharm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bpa-solutions.net\/wp-content\/uploads\/2013\/12\/Debiopharm-Investment-300x54-1.jpg","keywords":["Debiopharm","funds","investor"],"articleSection":["BPA Solutions","News","Press Release"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.bpa-solutions.net\/bpa-get-funds-from-debiopharm\/","url":"https:\/\/www.bpa-solutions.net\/bpa-get-funds-from-debiopharm\/","name":"BPA Solutions get Investment Funds from Debiopharm Investment - BPA Solutions","isPartOf":{"@id":"https:\/\/www.bpa-solutions.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bpa-solutions.net\/bpa-get-funds-from-debiopharm\/#primaryimage"},"image":{"@id":"https:\/\/www.bpa-solutions.net\/bpa-get-funds-from-debiopharm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bpa-solutions.net\/wp-content\/uploads\/2013\/12\/Debiopharm-Investment-300x54-1.jpg","datePublished":"2013-12-02T11:22:42+00:00","dateModified":"2023-07-10T08:27:33+00:00","breadcrumb":{"@id":"https:\/\/www.bpa-solutions.net\/bpa-get-funds-from-debiopharm\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bpa-solutions.net\/bpa-get-funds-from-debiopharm\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.bpa-solutions.net\/bpa-get-funds-from-debiopharm\/#primaryimage","url":"https:\/\/www.bpa-solutions.net\/wp-content\/uploads\/2013\/12\/Debiopharm-Investment-300x54-1.jpg","contentUrl":"https:\/\/www.bpa-solutions.net\/wp-content\/uploads\/2013\/12\/Debiopharm-Investment-300x54-1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.bpa-solutions.net\/bpa-get-funds-from-debiopharm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.bpa-solutions.net\/"},{"@type":"ListItem","position":2,"name":"BPA Solutions get Investment Funds from Debiopharm Investment"}]},{"@type":"WebSite","@id":"https:\/\/www.bpa-solutions.net\/#website","url":"https:\/\/www.bpa-solutions.net\/","name":"Solutions BPA","description":"Intuitive, secure, intelligent eQMS on SharePoint Microsoft 365 AI","publisher":{"@id":"https:\/\/www.bpa-solutions.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bpa-solutions.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.bpa-solutions.net\/#organization","name":"Solutions BPA","url":"https:\/\/www.bpa-solutions.net\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.bpa-solutions.net\/#\/schema\/logo\/image\/","url":"https:\/\/www.bpa-solutions.net\/wp-content\/uploads\/2023\/05\/BPA-Solutions.svg","contentUrl":"https:\/\/www.bpa-solutions.net\/wp-content\/uploads\/2023\/05\/BPA-Solutions.svg","width":301,"height":68,"caption":"BPA Solutions"},"image":{"@id":"https:\/\/www.bpa-solutions.net\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/BPASolutions?fref=ts","https:\/\/x.com\/BPA_SOLUTIONS"]},{"@type":"Person","@id":"https:\/\/www.bpa-solutions.net\/#\/schema\/person\/1752d1ec96e94ebb1316bd53a2bd57ae","name":"Boris Lutz","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/7a92d8e8012b5fadbae634d6ed1315aa081e51ebf627599d0e53bd99e362775c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7a92d8e8012b5fadbae634d6ed1315aa081e51ebf627599d0e53bd99e362775c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7a92d8e8012b5fadbae634d6ed1315aa081e51ebf627599d0e53bd99e362775c?s=96&d=mm&r=g","caption":"Boris Lutz"}}]}},"_links":{"self":[{"href":"https:\/\/www.bpa-solutions.net\/fr\/wp-json\/wp\/v2\/posts\/6675","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bpa-solutions.net\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bpa-solutions.net\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bpa-solutions.net\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bpa-solutions.net\/fr\/wp-json\/wp\/v2\/comments?post=6675"}],"version-history":[{"count":0,"href":"https:\/\/www.bpa-solutions.net\/fr\/wp-json\/wp\/v2\/posts\/6675\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.bpa-solutions.net\/fr\/wp-json\/wp\/v2\/media?parent=6675"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bpa-solutions.net\/fr\/wp-json\/wp\/v2\/categories?post=6675"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bpa-solutions.net\/fr\/wp-json\/wp\/v2\/tags?post=6675"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}